PV Bulletin

Tag archive

final

publicSwissmedic · Switzerland · Updated Jun 19, 2026

Swissmedic Guidance on Injectable Products for Wrinkle Treatment

Urgency: High

Healthcare professionals must report all serious incidents involving injectable devices to Swissmedic as outlined in the new guidance.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Guidance
Read impact briefarrow_forward
publicTherapeutic Goods Administration (TGA) · Australia · Updated Jun 18, 2026

Update to listed medicine ingredients in June 2026

Urgency: High

Sponsors must align their products with the updated safety and formulation requirements for permissible ingredients as per the new determination.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Notice
Read impact briefarrow_forward
publicFDA · USA · Updated Jun 4, 2026

FDA Final Guidance on Postapproval Requirements and Resources for ANDAs

Urgency: Low

Review the guidance to ensure compliance with post-marketing safety reporting timelines and annual report submissions; update SOPs for ICSR processing and periodic report generation.

Country ComplianceICSRRegulatory Intelligence Lead
SOP Impact3 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Labeling Lead, QPPV
verifiedRegulatory action: Guideline
Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only